Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
0460:HKG
Sihuan Pharmaceutical Holdings Group Ltd
HK$1.33
+1.53%
(+0.020) 1D
Apr 24, 2:25:42 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0460...
Open
HK$1.32
High
HK$1.34
Low
HK$1.30
Mkt. cap
12.16B
Avg. vol.
28.51M
Volume
18.77M
Dividend
1.64%
Quarterly dividend
HK$0.01
Ex dividend date
Jun 30, 2026
P/E ratio
58.85
52-wk high
HK$1.92
52-wk low
HK$0.63
EPS
HK$0.02
Shares outstanding
9.47B
No. of employees
3K
News stories
From sources across the web
Profile
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market. Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
About Sihuan Pharmaceutical Holdings Group Ltd
CEOGuo Weicheng
Employees2.84K
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitesihuanpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
573.10M
573.10M
735.90M
735.90M
Cost of goods sold
194.47M
194.47M
213.60M
213.60M
Cost of revenue
194.47M
194.47M
213.60M
213.60M
Research and development expenses
76.42M
76.42M
69.21M
69.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
221.66M
221.66M
337.39M
337.39M
Operating expense
275.58M
275.58M
386.99M
386.99M
Total operating expenses
470.05M
470.05M
600.59M
600.59M
Operating income
103.05M
103.05M
135.31M
135.31M
Other non operating income
-
-
-
-
EBT including unusual items
78.46M
78.46M
130.12M
130.12M
EBT excluding unusual items
72.60M
72.60M
111.67M
111.67M
Income tax expense
45.36M
45.36M
70.51M
70.51M
Effective tax rate
57.82%
57.82%
54.19%
54.19%
Other operating expenses
-22.51M
-22.51M
-19.61M
-19.61M
Net income
51.30M
51.30M
38.55M
38.55M
Net profit margin
8.95%
8.95%
5.24%
5.24%
Earnings per share
-
-
-
-
Interest and investment income
24.80M
24.80M
24.62M
24.62M
Interest expense
-52.48M
-52.48M
-48.30M
-48.30M
Net interest expenses
-27.69M
-27.69M
-23.69M
-23.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
152.06M
152.06M
184.32M
185.33M
Gain or loss from assets sale
-5.87M
-5.87M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer